Century Therapeutics (IPSC)
Develops iPSC-derived allogeneic cell therapies for autoimmune disease and cancer.
$1.81
vs last close−0.08 (−4.23%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.12
Revenue estimate
$1.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.43$0.89−$0.38−$0.32−$0.25−$0.11−$0.17Pending
Estimate−$0.45−$0.31−$0.38−$0.39−$0.28−$0.15−$0.11−$0.12
Surprise+4.4%+387.1%0.0%+17.9%+10.7%+26.7%−54.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.2M$109.2M—————Pending
Estimate$49.6M$41.3M$25.0K−$83.3K−$62.5K$2.9M$2.2M$1.6M
Surprise−91.6%+164.4%——————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.12 | — | — |
| Sep 2027 | −$0.12 | — | — |
| Jun 2027 | −$0.12 | — | — |
| Mar 2027 | −$0.12 | — | — |
| Dec 2026 | −$0.13 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.11 | −$0.17 | −54.5% |
| May 2026 | −$0.15 | −$0.11 | +26.7% |
| Mar 2026 | −$0.28 | −$0.25 | +10.7% |
| Nov 2025 | −$0.39 | −$0.32 | +17.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Jun 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.12 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.12 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.12 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.12 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.13 | — | — | $1.2M | — | — | — |
| Nov 12, 2026 | −$0.12 | — | — | $1.6M | — | — | — |
| Aug 12, 2026 | −$0.11 | −$0.17 | −54.5% | $2.2M | — | — | −4.9% |
| May 13, 2026 | −$0.15 | −$0.11 | +26.7% | $2.9M | — | — | −0.4% |
| Mar 12, 2026 | −$0.28 | −$0.25 | +10.7% | −$62.5K | — | — | −8.4% |
| Nov 13, 2025 | −$0.39 | −$0.32 | +17.9% | −$83.3K | — | — | −17.5% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Jun 21, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |